BofA lowered the firm’s price target on Exelon to $36 from $38 and keeps a Neutral rating on the shares. Following the adverse Illinois regulatory decision, the firm expects a long-term EPS growth rate reduction with Q4 earnings. The firm forecasts about a 6% EPS growth rate in 2023-2027, supporting a 5-7% outlook, which is lower than the current 6-8% rate, the analyst tells investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on EXC: